NFKB1 and diffuse large B-cell lymphoma: The authors show that second mitochondria-derived activator of caspase (SMAC) mimetics target cIAP1/2 for destruction, thereby suppressing NF-κB and selectively killing ABC DLBCL cells depending on this signaling cascade, providing the perspective of future therapeutic strategies against this lymphoma subtype.